CJC-1295 DAC

CJC-1295 DAC is a research peptide studied for its interaction with GHRH receptor with extended half-life DAC modification pathways involved in sustained GH and IGF-1 release. These pathways play a role in cellular signaling, receptor modulation, and downstream biological responses. In research models, CJC-1295 DAC has been associated with changes in extended GH/IGF-1 release markers and GHRH receptor activity, making it a compound of interest in endocrine and pituitary studies. For research purposes only. Not intended for human or veterinary use.